RAPP
Rapport Therapeutics, Inc. Common Stock
NASDAQHealthcareBiotechnologyUS
USD41.80
+1.41 (+3.49%)
Rating:C
Company Profile
CEO
Abraham N. Ceesay
IPO Date
2024-06-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$40.40
Prev. Close
$40.39
Day Low
$39.69
Day High
$43.76
52W Low
$11.05
52W High
$43.75
Market Cap
$1.53B
Volume
0.42M